METOCLOPRAMIDE-ASSOCIATED TARDIVE-DYSKINESIA IN HEMODIALYSIS-PATIENTS WITH DIABETES-MELLITUS - 2 CASE-REPORTS

被引：11

作者：

SEWELL, DD ^{[1
]}

YOSHINOBU, BH ^{[1
]}

CALIGIURI, MP ^{[1
]}

JESTE, DV ^{[1
]}

机构：

[1] UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093

来源：

GENERAL HOSPITAL PSYCHIATRY | 1992年 / 14卷 / 06期

关键词：

D O I：

10.1016/0163-8343(92)90009-Y

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Metoclopramide, a drug used almost exclusively for medical indications, is a dopamine (D-2) receptor blocker and has been reported to cause extrapyramidal side effects. We present two case reports of hemodialysis patients who were treated with metoclopramide for diabetic gastroparesis. Within 12 months of beginning treatment, both patients developed persistent tardive dyskinesia, These cases highlight the fact that some patients who benefit from metoclopramide may also have a relatively high risk of developing persistent tardive dyskinesia. The consultation-liaison psychiatrist can play an important role in the education of the medical staff regarding metoclopramide-induced tardive dyskinesia.

引用

页码：416 / 419

页数：4

共 25 条

[1] EXTRAPYRAMIDAL REACTIONS WITH METOCLOPRAMIDE [J].

BATEMAN, DN ;

RAWLINS, MD ;

SIMPSON, JM .

BRITISH MEDICAL JOURNAL, 1985, 291 (6500) :930-932

[2]

BORDA IT, 1987, CLIN PHARM ELDERLY, P529

[3]

Borenstein P, 1965, Therapie, V20, P975

[4]

CHAFFEE BJ, 1991, CLIN PHARMACY, V10, P430

[5]

GANZINI L, 1991, ARCH GEN PSYCHIAT, V48, P259

[6]

GRIMES JD, 1982, CAN MED ASSOC J, V126, P23

[7] METOCLOPRAMIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE [J].

HARRINGTON, RA ;

HAMILTON, CW ;

BROGDEN, RN ;

LINKEWICH, JA ;

ROMANKIEWICZ, JA ;

HEEL, RC .

DRUGS, 1983, 25 (05) :451-494

[8]

JESTE DV, 1988, J CLIN PSYCHOPHARM, V8, pS38

[9]

JESTE DV, 1981, AM J PSYCHIAT, V138, P297

[10]

KANE JM, 1992, TARDIVE DYSKINESIA T

← 1 2 3 →